Treatment of vaginal atrophy using a low-intensity laser
Official title: Study of the Efficiency and Safety of Low-Intensity Neodymium Laser Radiation With a Nanosecond Pulse Duration for Treatment of the Vaginal Walls Atrophic Changes
Run by MeLSyTech, Ltd · NCT05335317 · Data updated 2026-11-12
This study is testing whether a low-intensity laser treatment can improve vaginal health in postmenopausal women who are dealing with vaginal atrophy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 75 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | MeLSyTech, Ltd Industry-sponsored |
| Drugs / interventions | radiation |
| Locations | 1 site (Nizhny Novgorod) |
| Status | Recruiting |
| Started | April 18, 2022 |
| Main results expected | September 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | December 12, 2024 |
| Trial ID | NCT05335317 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 40-75 with vaginal atrophy or mild vaginal prolapse.
✕Probably not a fit
Patients with a history of oncological diseases or severe vaginal prolapse will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effects of low-intensity neodymium laser treatment on the vaginal wall in postmenopausal women experiencing vaginal atrophy. Participants will be divided into three groups: one receiving laser treatment, another receiving topical hormone therapy, and a control group receiving no treatment. Various assessments, including vaginal health indices and imaging techniques, will be conducted before and after treatment to measure changes in vaginal health. The study will involve up to 120 participants, with follow-up visits scheduled after the treatment procedures.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for women suffering from vaginal atrophy.
How similar studies have gone: Other studies have shown promising results with laser treatments for vaginal atrophy, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age of 40-75 years, inclusive; * Vaginal atrophy or 1st grade vaginal prolapse with atrophy, or lack of vaginal atrophy in case of control group 2; * All participants have informed consent to conduct a course of procedures according to protocol, carry out follow-up visits, and conduct studies. Exclusion Criteria: * Age of under 40 and over 75 years old; * History of oncological diseases; * Active tuberculosis; * Inflammatory diseases of the vulva and vagina including genital herpes in the acute stage; * Urinary tract infections; * Damage to the vaginal mucosa; * Pregnancy; * Tendency to photoallergy including taking photosensitizing drugs (diuretics, antihistamines, antipsychotics); * Porphyria; * Cardiac deficiency of 2-3 degrees; * Chronic renal disease; * Participants with greater than 1st grade vaginal prolapse; * Women after childbirth up to 8 weeks; * Participants who, according to the doctor, are not able to complete the study; * Protocol non-compliance of laser exposure sessions; * Voluntary refusal to participate in the study; * Violation of recommendations for the management of the period after laser treatment; * Adverse events that occurred during laser processing and research, and associated with them. * The appearance of contraindications listed in the Exclusion criteria.
Where it's running
-
State-Funded Healthcare Institution of the Nizhny Novgorod region "Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko"
Nizhny Novgorod, Russia Recruiting
Study contacts
- Principal investigator: Liya Z Sirotina — Privolzhsky Research Medical University
- Study coordinator: Ksenia V Shatilova, Ph.D.
- Email: shatilova@melsytech.com
- Phone: +79262792700
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
F-GYN injection for vaginal dryness and vaginal/vestibular atrophy
This study tests whether a one-time F-GYN injection can relieve vaginal dryness and related symptoms in adult women with atrophic vaginitis/vestibulovaginal atrophy compared with standard non-hormonal care.
-
AI-assisted relaxation and breathing training for postmenopausal women with chronic pain
This study tests whether AI-guided relaxation and breathing training, compared with physiotherapist-led training and a no-structured-training control, can help postmenopausal women manage chronic musculoskeletal pain.
-
Pixel CO2 (FemiLift) laser treatment for vulvo-vaginal atrophy
This trial tests whether the Pixel CO2 (FemiLift) laser can relieve symptoms and restore healthier vaginal tissue in postmenopausal women with vulvo-vaginal atrophy.
-
Comparing two procedures for treating stress urinary incontinence during vaginal prolapse repair
This study is testing whether a new type of surgery or an injection is better for helping women with stress urinary incontinence during vaginal prolapse repair.
-
Treatment for vaginal atrophy and related conditions using a novel gel dressing
This study is testing a new gel dressing to see if it can help adult women with vaginal atrophy and other skin conditions feel better.
-
Using vaginal estrogen to improve sexual function in breastfeeding patients after childbirth
This study tests if using vaginal estrogen cream can help breastfeeding women improve their sexual function after giving birth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.